COMMUNIQUÉS West-GlobeNewswire
-
EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution
10/10/2024 - 20:38 -
EUROAPI finalise le financement de son plan FOCUS-27 et poursuit son exécution
10/10/2024 - 20:38 -
QC Kinetix Celebrates PA Week Honoring Physician Assistants as 'The Miraculous Midlevel'
10/10/2024 - 19:08 -
Olansky Dermatology & Aesthetics co-founder Dr. David Olansky retires after more than 40 years of clinical practice
10/10/2024 - 18:24 -
Monthly information related to total number of voting rights and shares composing the share capital – October 8, 2024
10/10/2024 - 18:00 -
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 8 octobre 2024
10/10/2024 - 18:00 -
Renowned Hypnotherapist Dr. Steve G. Jones Brings Hollywood's Best-Kept Wealth Secret to the Public
10/10/2024 - 17:57 -
Press release: Transparency Notification from Shareholders
10/10/2024 - 17:40 -
BioPorto Announces Appointment of National Principal Investigator and Selection of CRO for Upcoming USA ICU Adult AKI Clinical Study
10/10/2024 - 16:17 -
$3.8 Million Department of Defense Grant Awarded for Groundbreaking Study on Safe and Sound Protocol in PTSD Treatment
10/10/2024 - 16:00 -
Nextech to Discuss Responsible AI in Healthcare at Eyecelerator
10/10/2024 - 16:00 -
Wake Radiology Welcomes New Director of Business Development, Bonnie Little-Hildebrandt, MHA
10/10/2024 - 16:00 -
The Black Car Fund Partners with CirrusMD to Provide 24/7 Virtual Primary Care to Tens of Thousands of Eligible Drivers in New York State at No-Cost
10/10/2024 - 15:15 -
CenTrak Named Global Healthcare RTLS Company of the Year by Frost & Sullivan
10/10/2024 - 15:05 -
Spinach® Is the Number One Cannabis Brand in Canada
10/10/2024 - 15:00 -
Amydis to Present First Ocular Tracer Designed to Detect Transthyretin Amyloidosis (ATTR) at AAOOP Conference
10/10/2024 - 15:00 -
Labviva Named BostInno Fire Awards Honoree
10/10/2024 - 15:00 -
NEXGEL Preannounces Expected Record Third Quarter 2024 Revenue of $2.85 Million, an Increase of Approximately 133% Year-Over-Year and 98% Sequentially
10/10/2024 - 15:00 -
International Myeloma Foundation Launches Clinical Trial Matching Engine in Partnership with SparkCures
10/10/2024 - 14:45
Pages